Chronic hepatitis B with human immunodeficiency virus co-infection

Description

A liver disease characterised by liver inflammation and fibrosis caused by more than 6 months of infection with the hepatitis B virus and with the human immunodeficiency virus (HIV). Clinical features include fatigue, hard liver edge and complications of cirrhosis (muscle wasting, ascites, splenomegaly/portal hypertension), and outcomes, including hepatocellular carcinoma are worse than for hepatitis B without HIV infection.

Index terms

Chronic hepatitis B with human immunodeficiency virus co-infection
Chronic hepatitis B, co-infected with human immunodeficiency virus, with cirrhosis
Chronic hepatitis B, co-infected with human immunodeficiency virus, with cirrhosis, with cirrhosis-related complications

Show allHide

Chronic hepatitis B, co-infected with human immunodeficiency virus, with cirrhosis, without cirrhosis-related complications
Chronic hepatitis B, co-infected with human immunodeficiency virus, without cirrhosis

Exclusions from above levels

DB92 – Non-alcoholic fatty liver disease
DB94 – Alcoholic liver disease
DB96.0 – Autoimmune hepatitis

Show allHide

1F00.Y – Herpes simplex hepatitis
DB92.1 – Non-alcoholic steatohepatitis
NE83.1 – Infection arising from device, implant or graft, not elsewhere classified

Sibling codes

1E51.0Y – Other specified chronic hepatitis B
1E51.0Z – Chronic hepatitis B, unspecified

Foundation entity

Chronic hepatitis B with human immunodeficiency virus co-infection – http://id.who.int/icd/entity/1994012056

Allowed postcoordination axes

Part of: 1E51.0: Chronic hepatitis B › 1E51: Chronic viral hepatitis › 01: Certain infectious or parasitic diseases